Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The NADH:Ubiquinone Oxidoreductase Core Subunit V1 (NDUFV1) is a component of the mitochondrial NADH dehydrogenase complex I, crucial for electron transport and oxidative phosphorylation. It contains sites for NADH binding, flavin mononucleotide, and iron-sulfur clusters, facilitating the transfer of electrons from NADH to ubiquinone while pumping protons across the inner mitochondrial membrane. This process is vital for ATP synthesis. Defects in complex I, including those involving NDUFV1, are linked to mitochondrial disorders and neurodegenerative diseases[1][2][3].
Electron transfer from NADH to ubiquinone, proton translocation across the inner mitochondrial membrane
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NADH:Ubiquinone Oxidoreductase Core Subunit V1 (NDUFV1).